Ryan Cole
Vermogen: 2 M $ op 30-09-2026
Vermogen: 2 M $ op 30-09-2026
Mr. Ryan Cole, CPA, is a Chief Operating Officer at Tang Capital Acquisition Corp., a Chief Operating Officer at Kezar Life Sciences, Inc. and a Chief Operating Officer at Aurinia Pharmaceuticals, Inc. Mr. Cole was previously employed as a Senior Vice President-Operations by Odonate, Inc. and a Senior Auditor by Ernst & Young LLP.
He received his undergraduate degree from Santa Clara University.
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
| 18-05-2026 | 116.144 ( 0,09% ) | 2 M $ | 30-09-2026 |
| Bedrijven | Functie | Begin |
|---|---|---|
| AURINIA PHARMACEUTICALS INC. | Operationeel Directeur | 23-03-2026 |
| KEZAR LIFE SCIENCES, INC. | Operationeel Directeur | 11-05-2026 |
| Bedrijven | Functie | Einde |
|---|---|---|
Ernst & Young LLP
Ernst & Young LLP Miscellaneous Commercial ServicesCommercial Services Provides assurance, auditing, tax, legal, technology and consulting & managed services | Comptroller/Controller/Auditor | 01-05-2012 |
| ODONATE, INC. | Operationeel Directeur | - |
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
| Bedrijven in privébezit | 5 |
|---|---|
Ernst & Young LLP
Ernst & Young LLP Miscellaneous Commercial ServicesCommercial Services Provides assurance, auditing, tax, legal, technology and consulting & managed services | Commercial Services |
Santa Clara University
Santa Clara University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Aurinia Pharmaceuticals, Inc.
Aurinia Pharmaceuticals, Inc. BiotechnologyHealth Technology Operates as a biopharmaceutical company, which focuses on discovery and development of immunomodulating therapeutics | Health Technology |
Kezar Life Sciences, Inc.
Kezar Life Sciences, Inc. BiotechnologyHealth Technology Discovers and develops therapies targeting protein homeostasis | Health Technology |
Odonate, Inc.
Odonate, Inc. Pharmaceuticals: MajorHealth Technology Develops therapeutics for cancer treatment | Health Technology |
Kies jouw editie
Alle financiële informatie op nationaal niveau